Philip Morris
Passive Smoking Increases Experimental Atherosclerosis in Cholesterol-Fed Rabbits
Fields
- Author
- Glantz, S.A.
- Isenberg, W.M.
- Parmley, W.W.
- Sievers, R.E.
- Sun, Y.P.
- Zhu, B.Q.
- Isenberg, W.M.
- Type
- PSCI, PUBLICATION SCIENTIFIC
- BIBL, BIBLIOGRAPHY
- Area
- SCIENTIFIC AFFAIRS/BLACK LATERAL OLD S&T
- Document File
- 2023511660/2023512308/Ets: Heart Disease 930900
- Litigation
- Okag/Privilege Withdrawn
- Okag/Produced
- Characteristic
- EXTR, EXTRA
- Site
- R529
- Named Organization
- Langan Products
- Moffitt Hospital
- Stanford Univ
- Univ of Ca San Francisco
- Univ of Ma Worcester
- Cardiovascular Research Inst
- Epa, Environmental Protection Agency
- George Smith Fund
- Moffitt Hospital
- Author (Organization)
- Cardiovascular Research Inst
- Jacc
- Univ of Ca San Francisco
- Jacc
- Named Person
- Hammond, S.K.
- Hudson, J.
- Langan, L.
- Ott, W.
- Parmley, W.W.
- Repace, J.
- Sumner, P.E.
- Hudson, J.
- Master ID
- 2023511661/2307
Related Documents:- 2023511661-2307 Environmental Tobacco Smoke and Heart Disease
- 2023511710 the Relationship of Passive Smoking to Various Health Outcomes Among Seventh-Day Adventists in California.
- 2023511714-1718 Passive Smoking and the Risk of Heart Attack or Coronary Death
- 2023511722-1727 Effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers A Prospective Study
- 2023511728 Erratum
- 2023511729 'effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers: A Prospective Study'
- 2023511730 the First Author Replies
- 2023511734-1737
- 2023511738-1744 Passive Smoking in Females and Coronary Heart Disease
- 2023511749-1756 Original Contributions Heart Disease Mortality in Nonsmokers Living with Smokers
- 2023511760-1781 Lung Cancer in Japan: Effects of Nutrition and Passive Smoking
- 2023511785-1789 Passive Smoking and Cardiorespiratory Health in A General Population in the West of Scotland
- 2023511790 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511791-1792 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511793-1795 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511800-1802 Public Health Briefs Passive Smoking and 20-Year Cardiovascular Disease Mortality Among Nonsmoking Wives, Evans County, Georgia
- 2023511806-1816 Relationship of Passive Smoking to Risk of Lung Cancer and Other Smoking-Associated Diseases
- 2023511818 Increased Incidence of Heart Attacks in Nonsmoking Women Married to Smokers
- 2023511822-1824 Cvd Epidemiology Newsletter
- 2023511829-1841 Original Contributions Effects of Passive Smoking in the Multiple Risk Factor Intervention Trial
- 2023511842 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511843-1844 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511845 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511846 the Authors Reply
- 2023511849-1853 Smoking As A Risk Factor for Cerebral Ischemia
- 2023511857-1862 Urinary Cotinine Measurement in Patients with Buerger's Disease - Effects of Active and Passive Smoking on the Disease Process
- 2023511865-1881 An Estimate of Adult Mortality in the United States From Passive Smoking
- 2023511882 Editorial Cardiovascular Risks of Environmental Tobacco Smoke
- 2023511883-1887 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511888-1890 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511891-1892 Ischemic Heart Disease: Response to Lee
- 2023511893-1895 Rebuttal to Lee / Katzenstein Commentary on Passive Smoking Risk
- 2023511896-1899 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511900-1906 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response to Criticism
- 2023511908-1911 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511912 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511913 Passive Smoking in New Zealand
- 2023511914 Passive Smoking in New Zealand
- 2023511915 Passive Smoking in New Zealand
- 2023511916 Passive Smoking and Passive Thinking
- 2023511918-1937 Cardiovascular Diseases and the Work Environment A Critical Review of the Epidemiological Literature on Chemical Factors
- 2023511939-1950 Clinical Progress Series Passive Smoking and Heart Disease Epidemiology, Physiology, and Biochemistry
- 2023511952-1957 Review Passive Smoking and the Risk of Heart Disease
- 2023511958-1961 Aha Medical / Scientific Statement Position Statement Environmental Tobacco Smoke and Cardiovascular Disease A Position Paper From the Council on Cardiopulmonary and Critical Care, American Heart Association
- 2023511965-1983 the Health Consequences of Involuntary Smoking A Report of the Surgeon General
- 2023511985-1998 Environmental Tobacco Smoke Measuring Exposures and Assessing Health Effects
- 2023512000-2015 Environmental Tobacco Smoke Proceedings of the International Symposium at Mcgill University 890000 Environmental Tobacco Smoke and Cardiovascular Disease: A Critique of the Epidemiological Literature and Recommendations for Future Research
- 2023512016-2028 Panel Discussion on Cardiovascular Disease
- 2023512030-2037 Indoor Air Quality and Ventilation Environmental Tobacco Smoke (Ets) and Cardiovascular Disease
- 2023512039-2054 A Critique of the Methods Used to Assess the Toxic Effects on Man of Combustion Products.
- 2023512056-2066 Coronary Heart Disease and Involuntary Smoking
- 2023512068-2077 7. Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512079-2088 Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512090-2091 Editorial Give A Dog-End A Bad Name
- 2023512093-2108 Weaknesses in Recent Risk Assessments of Environmental Tobacco Smoke
- 2023512110-2129 Environmental Tobacco Smoke and Mortality A Detailed Review of Epidemiological Evidence Relating Environmental Tobacco Smoke to the Risk of Cancer, Heart Disease and Other Causes of Death in Adults Who Have Never Smoked - 5 Heart Disease
- 2023512131-2155 Environmental Tobacco Smoke Exposure and Occupational Heart Disease
- 2023512157-2171 Passive Smoking and Coronary Artery Disease. Biological Plausibility and Severity of Effect
- 2023512173-2180 Carbon Monoxide and Cardiovascular Disease: An Analysis of the Weight of Evidence
- 2023512185-2189 the Effects of Passive Inhalation of Cigarette Smoke on Excercise Performance
- 2023512192-2195 Effect of Passive Smoking on Angina Pectoris
- 2023512199-2202
- 2023512203-2213 Effect of 'passive' Smoking on the Physical Load Tolerance of Coronary Heart Disease Patients
- 2023512216-2220 Indoor Passive Smoking: Its Effect on Cardiac Performance
- 2023512223-2224 Passive Smoking Severely Decreases Platelet Sensitivity to Antiaggregatory Prostaglandins
- 2023512227-2230 Platelet Sensitivity to Prostacyclin in Smokers and Non-Smokers
- 2023512233-2237 Besitzen Passivraucher Ein Erhohtes Thromboserisiko?
- 2023512241-2244 Passive Smoking Affects Endothelium and Platelets
- 2023512247-2253 Lipoprotein and Oxygen Transport Alterations in Passive Smoking Preadolescent Children the Mcv Twin Study
- 2023512256-2257 Abstracts of the 30th Annual Conference on Cardiovascular Disease Epidemiology Children's Hdl-Chol: the Effects of Tobacco: Smoking, Smokeless and Parental Smoking
- 2023512261-2266 Passive Smoking Alters Lipid Profiles in Adolescents
- 2023512269-2274 Serum Lipids & Lipoprotein Profiles of Cigarette Smokers & Passive Smokers
- 2023512278-2279 8th Worldconference on Tobacco or Health Building A Tobacco-Free World 920330 - 920403 Buenos Aires - Argentina Abstracts, Posters and Videos. Serum Lipoproteins in Nonsmokers Chronically Exposed to Tobacco Smoke in the Workplace
- 2023512282 the Association Between Carotid Arterial Wall Thickness and Active and Passive Cigarette Smoking
- 2023512285 Passive Smoking and Carotid Artery Wall Thickness: the Aric Study
- 2023512300-2301 Supplement to Circulation Abstracts From the 65th Scientific Sessions New Orleans Convention Center New Orleans, Louisiana 921116 - 921119
- 2023512304-2307 Association of Passive Smoking with Increased Coronary Heart Disease Risk Is Not Explained by Elevation of Leucocyte Count
- Date Loaded
- 24 May 1999
- UCSF Legacy ID
- qjc02a00
Document Images
JACC Vol. 21l No. I
January 1993=5-32
ar,
J
J
j
rw'
Cl,a
css-
«an.
EXPERIMENTAL STUDIES
Passive Smoking Increases Experimental Atherosclerosis in
Cholesterol-Fed Rabbits
BO-QING ZHU, MD, YI-PING SUN,, MD, RICHARD E. SIEVERS, BS, WILLIAM M. ISENBERG, PHD,
STAI*TTON. A. GLANTZ, PxD, FACC, WILLIAIvf W. PARMLEY, MD, FACC
San Francisco, California
Objectives. We evaluated'the influence of passive smoking on
experimental atherosclerosis in cholesterol-fed rabbits.
Background. Exposure to environmental tobacco smoke (ETS))
has been ~ epidemiologically linked' to death from ischernic heart
disease in nonsmokers.
Methods. New Zealand male rabbits were randomly divided
into tltree groups after 2 weeks of a 0.3% cholesterol i diet. Sixteen
rabbiu were exposed to a high and 16 rabbits Wa low dose of
ETS; 32 rabbits located' in another room served as an unexposed
control group. After 10 weeks of ETS exposure, all rabbits were
killed, and the percent of aortic and pttlmonaryarteryendotheiial
surfaces covered by lipid lesions was measured by, staining and
planimetry..
Results. Average air nicotine, carbon monoxide and total
particulate concentrations were 1,040 Ecglm3', 60.2 ppm and
32.8 mgim3 for the high dose ETS group, 30 pglm3,18.8 ppm and
4.0' mglm3 for the low dose ETS group and <1 µgimi, 3.1 ppm
an&0.13 mg/m3 for the control group. The percent atherosclerotic
Environmental tobacco smoke (ETS) is the term used to
describe tobacco combustion products inhale& by nonsmok-
ers in the proximity, of burning tobacco. More than 4,000
,;onstituents have beem identified in cigarette smoke. Most,
~ c,;u~ure to ETS is from sidestream smoke emitted from the
blltning tip of the cigarette. Sidestream smoke is hazardous
because it contains high, concentrations of ammonia, ben-
zene,, nicotine, carbon monoxide and many other carcino-
gens and irritants (1-3).
Passive smoking - involves breathing both sidestrearn
smoke that goes directNy into the aib from the burning tobacco
products and~ mainstream smoke after it has been exhaled ~ by
smokers. Sidestream smoke has higher concentrations of nox-
F,-om the Cardiovascular Divisioo. Department of Medicine and the Cudio-
vascular Re:search Ihstitute, Utuversity of Californiz San Fnncisen, Caldontii
This study was supponed in part by the Tobaeeo Reimed Disease Rcsnrzh ~
Progmii (Gran[~ 1 RT 145), University of Caldornia and the George Smith Fund.
All editonal'decisions for this arucle, including selection of referees, were
tnade by a Guest Editor. This policy appl)es to aU utieles with authors from
the Uaiversity of California, San Francisco,
Maausenpt received Much31, 1992: revised manuscript received July 7,
1992accepted July 15, 1992.
Address for corresuortdence: William W: Parmky, MD, 1186 MotUtt
Hosprtal. Uui.+ersttyof Califomtn, San Francisco. San Francisco, Califomia
94143-0124.
involvement of the aorta and pulmonarv artery increased signi5-
nntly with ETS exposure (for the aorta, 30'± 1996 [mean y SDj
for the control group, 36 ~: 14% for the low dose ETS group and,
52 = 21% for the high dose ETS group, p< 0:D01; for the
pulmonary artery, 22 = 15% for the control group+ 29 i 25% for
the low dose ETS group, an& 45 _ 1296 for the high dose ETS
group, p< 0.001): Bieeding tiine was significanUyshorter in the
two ETS groups than in the control group (86 = 17 vs. 68 = 15,
68 ~: 18 s, p < 0.001). There were no: signi5eant differences in
serum trigiycerides,,chole-sterol and'high density lipoprotein rbo-
lesterol at the end of the study.
Conclusiont. Environmental tobacco smoke affectU platelet
function and increases aortic and pulmonary artery atberosclero-
sis. This increase of atherosclerosis was independent of chaages in
serum lipids and exhibited a dose-response relation. These results
are consistent with data from epidemiologic studies demonstrating
that ETS increases the risk of death due to heart disease.
(J' A m Coll Cardio! l993;21:22,5-32)
ious compounds than does mainstream smoke. lt has been
estimated that approximately 50 million: nonsmoking adults
over the age of 35 years are regularly exposed to environmental
tobacco smoke. Addiuonally, 50% of all chilliren live in fami-
lies with one or more smokers (4): The effects of passive
smoking on health have been reported to include short-term~
effects, such as exacerbation of asthma and angina, as well as
long-tetm~effects, such as increased~ risk of lung cancer, respi-
ratory tract infection and atherosclerosis (1-7).
Environmental tobacco smoke adversely affects platelet
function and damages arteriali endothelium, and depresses
cellular respiration at the level of mitochondria (4',5). People
exposed toit have significantly thicker anenal walls than~do
unexposed nonsmokers, and wall thickness is increased with
increasing exposure (8). Passive smokers also have signifi-
cantly depressed high density lipoprotein (HDL),cholesterol
levels and significantly elevated ratios of total cholesterol to
HDL cholesterol levels. (9).
The materials in ETS may thus accelerate the develop-
ment of atherosclerotic plaque. Previous experimental
studies, however, showed' that exposure to smoke from
only 1 cigarette/day for 11 to 13 months failed to quantita-
tively affect atherosclerosis or serum lipids (S0). We de-
signed the present study toi further evaluate the influence
0735- I t)97/93156.00
3606 C 1993 by the American Coneae of Cardiology

2~5 ZHU ET AL.
PASStVESMOR]NG INCREASES ATHEROSCLEROSIS
of passive smoking on atherosclerosis in cholesterol-fed
rabbits.
Methods
Protocol. Sixty-four New Zealand male rabbits (2.0 to
2.6 kg) were randomly separated into three groups and fed a
high cholesterol! diet for 12 weeks. The cholesterol diet.
(Ziegler Bros., Inc.) contained 3% soybean oil and 0.3%
cholesterol by weight. The rabbits were housed in separate
cages in well mize& exposure chambers (BioClean, Duo.
Flo, model H 5500;, Lab Products Inc.), 1.92 m x 1.92 m~ x
0.97 m (3.58 m), that accommodated eight rabbits in each
group.
After 2 weeks on the diet, 16 rabbits, 8 at a time, were
exposed to a high dose of sidestream smoke (high ETS
group) from Marlboro filter cigarettes (4 cigarettes every,
151 mim for 6 h/day, 5 days/week) using a smoking machine
(Heinr. Borgwald GMBH' RM I/G, D-2000 Hamburg, Ger-
many) for 10 weeks from week 2 to week 12. Another 166
rabbits. 8 ao a time, were given a low dose of smoke Qow
ETS group) from the same smoking machine through 20.5
feet ofl 10-mm inside diameter plastic tube attached to the
mainstream port on the smoking machine. The smoke cooled
and the large particles settled out in this tube, making the
exposure level of the low ETS group similar to that of smoke
spread by the ventilation system of a building from an~ area
where smoke was permitted to nonsmoking areas of the
same building. Thirty-two rabbits, 16 at a time, located in the
same type of exposure chamber in another room~but with no
smoking machine, served as a control group eating the same
diet for 12 weeks, Three fans in the exposure chambers were
adjusted to ensure good mixing, using the measurement
devices discussed later. At the end of the 6-h exposure
period', the exhaust fan on the Biocleam unit was turned' on
and rapidly lowered the level of ETS pollution in the
exposure chamber to background levels corresponding to
those of the control animals until next day when the$ioclean
unit was turned off and~ the smoking machine was turned on
again.
Monitoring smolieezposure insid'e the ehambers. We mea-
sured several constituents of ETS in the three exposure
chambers: carbon monoxide (CO), total particulatesrespi-
rable suspended patticulatcs and nicotine.
To measure average carbom monoxide concentrations
during the 6-h exposure period, we used a model L15 CO
Personal Exposure System (Langan Products), every other
week for the three groups. We obtained an average daily
valtie taken from 2,520 samples during the exposure period
(3 h of ETS, I h break, 3 h of ETS) (Fig. 1).
To measure total particulate concentrations, we used' a
Miniram PDM-3 Optical Scattering Particle Monitor (MIE,
Inc.), monitoring particulate concentration every 1D~s, and
computed average total particulate concentrations during the
exposure period (Fig. 2): We obtained1hese data every other
week for all three groups. We also used a Piezobalance
JACC voll :1. No. I
Ianuary,1993125-32
Carbon Monoxltl.
(ppm) roa
95
90
e5
6o4 Hgh -B7
75
7 o
65-
6a
55
sa-
45
.0-1
35
30
25
20
,5
ro
5
Exposur p.rlotl.
Figure 1. Representative carbon monoxide (CO) concentrations
during a 24h period. During the period of exposure to environmen-
tal tobacco smoke (ETS) (3 h~of ETS, a 1-h break, 3 h,of ETS); the
average CO value from 2,520 samples is 53 ppm.
Respirable Aerosol Mass Monitor (model 3500 Thermo-
System) to measure respirable suspended particulates (11l)
on 4 different days, about, 10 sampieslday; to calibrate the
Iviiniram. The Piezobalance was factory, calibrated before
the study.
The Piezobalance measures the smaller respirable,sus-
pended particulates, whereas the Miniram measures total
particulates. To determine the relation between particulate
concentrations measuried;by the Miniram and Piezobalance,
we measured, average particulate concenuation values (37
values, each an average of~ 3 measurements) at different
levels of ETS using these two instruments simultaneously.
Figure 3 shows that there was a strong linear relation
between average particulate concentrations measured by the
Piezobalance and the Miniram, with the Piezobalance read-
ing about 36~'0 of that obtained by, the Miniram. This relation
is sinular to that found in a previous study (12) in which the
Miniram and the Piezobalance were compared in an envi-
ronmental chamber measuring ETS over a range of concen-
trations.
In addition, we monitored air nicotine levcls by using a
passive diffusion monitor~ (13)ithat was located in the middle
of the exposure chamber during the 6-h exposure period,
every other week for all three groups.
Hematologic and biochemical analysis. Bleeding time. cii'-
culating platelet aggregates, platelet count. hematoerit. he-
moglobin, totai'serum cholesterol, triglycendes. high density
lipoprotein (HDL) cholesterol and serum cotinine were
measured at the beginning of the study (before the rabbit3
started the high cholesterol diet) and at 6-week intervils
(that is, after 4 and' 10 weeks). The concentration d aodnine
was determined by gas chromatography with nitrogca-
phosphorus detection (14): This method has been modified
for simultaneous extraction of cotinine and detcratiaaboo
using capillary gas chromatography (15).
Bleeding time was determined after l'-min warming of the
rabbit's ear in a normal saline bath (37°C)1 A smaA stand9rd

JACC Vol. a. No. I
January 19912:3-32
n
Figure 2. Total suspended particulate eoncentrations
measured by the Miniram every, 10 s during a representa-
tive peno&of exposure to environmental tobacco smoke
(ETS) (3 h of ETS. a I-h break, 3 h of ETS). Average total
suspended particulate concentration ~ during the exposure
penod' was 23.7 mgim'. The peaks occur while the ciga-
rettes are actually being smoked. The large drop corre-
sponds to ithe 1-h middaybreaky
prick was made in the ear, avoiding macroscopic vessels.
The time fromithe initial bleeding to cessation of bleeding
was recorded as the bleeding time.
A platelet count ratio method (16) was used for, quantita-
tive determination of circulating platelet aggregates. One
mmoUliter adenosine diphosphate was added to a citrated
venous blood' sample before stirring, The sample was di-
vided into two tubes, one containing ethylenediaminetet-
raacetic acid (EDTA)/fotmalin~solution and the other EDTA
only. Platelet-rich plasma was collected after centrifugation.
Platelets im both samples were counted, using standard
techniques (Sequoia-Turner Corporation Operator Refer-
ence manual, Cell-Dyn 900 Hematology Analyzer). The
platelet aggregate ratio was calculated' from the platelet
count in the two solutions. The higher the ratio, the fewer
the platelet aggregates.
Figure 3: Relation~between average particulate concenuations mea-
sured by the Piezobalance (PZB) and the Miniram. Because of the
ezcellent llnear relation~ one can measure respirable suspended
particulates by taking 36Wof the readings obtained with the Mini-
ram.
.
Ar.r.yoportlea aone.nrnt/aWnIpnn,tJ) blWftkaM (1IJ
ZHU ET AL. 227
PASSIVE SMOKING INCREASES ATHEROSCLEROSIS
Tfmr
Total serum cholesterol and trigl,Ncende levels were de-
termined by automated enzymatic methods (Coulter DART
cholesterol reagent using the DACOS and DACOS XL
analyzers), and HDL cholesteroliconcentrations were mea-
sured after precipitation of other, lipoprotein classes with
dextran and magnesium ions (HDL cholesterol precipitant
(CacNo 236141)Ciba Corning Diagnostics Corp.). '
The blood samples were drawn in the morning (Tuesday
to Friday) after 12 h,of fasting and before ETS exposure. The
samples for plasma cotinine analysis also were taken,imthe
morning before exposure (17 h after the last ETS exposure).
Morphologic studies. At: week 1?, after 10'weeks of
exposure to ETS (or control conditions), all rabbits were
killed. After intravenous administration of pentobarbital,
130 mg/kg body weight, the aorta was removed from its
origin (2 cm dista1toithe aortic valve) down to the bifurcation
of the internal' iliac arteries; the pulmonary artery was
isolated from its beginning at the pulmonary vaJ4e to just
above the bifurcation. The vessels were opened by linear
vertical incision, fixed in a 104io formalin solution for 24 h,
stained with Sudan IV', then photographedl Finally, plani-
metric measurement of lipid lesions was performed quanti-
tatively by estimating the total stained' regions in photo-
graphs of each artery with a planimeter. The measurements
were performed in blinded'fashion and imduplicate.
Statistical analysis. The text and tables list data as the
mean value = SD; the figures summarize data as the mean
value = SEM. Data were analyzed by linear regrzssion..
using ETS dose as the independent'variable. Multiple linear
regression~was also used with aortic and pulmonary artery
lesions as the dependent variables, including choksterol
levels as well as exposure to smoke in the regtssion
equation to account for the possible effects of dtfferrnt
serum ~ cholesterol levels on the extent of lesions. Analysts of
variance (ANOVA) was used to compare observations
among the three experimental' groups. Data were analyzed
before and after exposure, as wclllas in terms of changes in

22$ Z.NU ET AL. ,
PASSIVE SMOKING INCREASES ATHEROSCLEROSIS
JACC Voll'-1. No. I
January 1993:225-32
Table 1l Average Air Nicotine, Carbon Monoxide and Particulate Concentrations in the Control and
Environmental Tobacco,
Smoke Chambers
Group
Air Nicotina
(pglm')
Air CO IPpm)! Total
P.rticulates'
(mgrm3) Resptrahle
Particutatest,
(mg!m3)
Control <1 In = 1!1 3.1 s 1.9 (n = 2) 0:13 _ 0!04 In = 10)', 0.07 t 0.06 (n = 10),
LowETS 30=31n=4), 18.8c2.2(n=5) 4.03z0149(n=3) 1.2=0.7In=8)
High ETS 1.040 _ 302 (n = 4) 60.2_ 14.3(n=5) 32:8z6.9(n=7) 13.8=3.5(n=6)
'By Miniram: *By Piezobalanee. Values are expressed as mean value _ SD. ni= the number of samples.
For nicotinc, carbon monoxide [CO] and'total
paruculates, each of the n samples represents the average value observed during the exposure period
(3'h of environmental tobacco smoke [ETSl, lib break. 3 h
o6 ETS)',on I' day. For examplcthe n= 2 values for Air CO in the controL group represenraverage
values recorded during 7 h on 2 diffcrcnt days. For respirable
particulates, the sample size represents the actual number of simple samples taken while the smoke
Ievel's were at steady state.
the measured variables before and after the 10-week expo-
sure perio& using paired r tests. We did not combine all data
into a single two-factor analysis of variance (with time
[before or after exposure) as one factor and ETS group.
[control, low ETS, high ETS]! as the second~ factor): we
believed that with~ such an approach~ the presence of a
control group (with no exposure) at both times would
generally lead to a significant interaction between time and
exposure group that would make the results of'tests on the
maini effects difficult to~ interpret. Data were processed by
using Minitab Versions 7.2 and 8.2. A p value < 0.05 was
taken as statistically significant.
Results
Weight gain. There was a similar initial body weight and
~ttl s?qu nt w,~ight gain in all'rthree groups of'irabbits througli-
olt(I_7~,voak period. The average body weight before
(week 2) and after 10 weeks of ETS exposure (week 12) was.
2.7 = 0.3 and 3.6 = 0.3 kg, respectively. There was no
significant difference in weight of the rabbits as assessed by
Ai`+t)V,\ before (p = 0.344) or after (p = 0.306) the 12-week
exp,;,iutcnt;al period. Similarly, ANOVA showed no signi6
cant differences in weight gain among the three exposure
groups (0.87 = 0.29 kg for the control group0.88 - 0.37 kg
for the low ETS group and 0;91 ± 0.36 kg for the high ETS
group; p= 0.923) or in food intake among the three groups,
either before (p = 0.398) or after (p = 0.43 1) exposure to
ETS. The average food intake before and after ETS expo
sure was 178 - 46 and 164 ± 58 glday, respectively. The
similarities in eating and weigttt gain across time and the
Tabl'e 2. Effects of Environmental Tobacco Smoke on Serum Lipids in,Choiesterol'.Fed Rabbits
Cboltsterol (mg/dl)
Group Before After
Conuol la ; 32) 671 = 278 1r09 - 483
Low ETS (n - 16) 480 : 279' 1.154 = 395
HighETS(n = 16Y 531 s 246 1.260 =532
different exposure groups indicate that any differences ob-
served in the exposure groups were not due to dietaryy
differences. There were no deaths during the 12-week study.
Smoke exposure inside the chamber. The average air
nicotine, carbom monoxide (CO) and total particulate con-
centrations during the 6-h exposure period are listed in Table
1. There were lrirge differences in air nicotine, CO and
particle concentrations between the groups with a high or
low leveli of ETS exposure and the controll group and
between the high and low ETS groups during the period of
exposure.
Altetrations in lipids. After rabbits were fed a high lipid!
diet, the serum cholesterol increased considerably in all'
animals during the 12-week period. The serum lipid levels for
the three groups (Table 2) show a similar increase in total
serum cholesteroll Total cholesterol may have been sligtitly
(p = 0.051) higher in the control group than in the two ETS
groups before the 10-week exposure period. There was no
significant difference (p > 018) among the three groups at the
end of the experiment. There were no significant differences
(p > 0.3) in triglycerides and HDL cholesterol among the
two ETS' groups and the control' group either before on after
the 10-week exposure period. There also were no significant
differences (p > 0.4) in the area under the cholesterol time
curve (cholesterol-weeks: 11,632' = 3,479'vs. 9,831 -- 3:048
and 10,349 t 3,182 mg/dl-wk), change (12-week value minus
2-week value) in cholesterol (538 = 463 vs. 674 - 419 and
729 - 627, 674 ± 419 mg/dl)change in triglycerides (13 - 84
vs. -63 ± 372 and~ 22 = 91 mg/dl) and change in HDL jU
Q
cholesterol (15 = 29 vs. 7= 22 and 16 :t 25 mg/dl),
~
~
Tnglycrndes Itog/dt) HDL Cbotesteml l(mg dl)
~
2V
,
Before ARer Before After N
91 : 72 78 s 51 40 = 16 55 :'7
102 t 93 165 _ 349 36 s 13 43 : 25
119 = 93 98 : Ill 37 _ 15 50i- 21
Vklues are expressed as mean value = SD. There were no significanudiffertnees(p > 03)'.mons the
three troups except for toul cholesterol beforc exposure
to eovironmental tobacco smoke (ETS). Values in the control group were higher than values in the
other two g'rwrps (p = 0.05). After = 12 weeks on lipid diet
and l0'weeks of smoke exposure; Before = 2 weeks on Gpid'diet and before smoke exposure; HDL - high
density, lipoprottin.
W
~
j

JACC Voll 21. 1<a, l
January 1993:'~t-32 ,
RSP Cone.ntnt/on,Dy. PZB (m01m')
Figure 4. Relation between log-plasma cotinine levels and log-
respirable suspended particulates (RSP) concentrations measured
by Piezobalance(PZB); ETS-H and ETS-L = groups witha high or
low level, respectively, of exposure to environmental tobacco
smoke.
respectively, among the control'group and the low and high,
ETS groups.
Cotinine levels in plasma. The plasma: cotinine levels at
the 6th week of ETS exposure in the control and the low an&
high ETS groups were <1.0, 6.0 t 4.3 and 1'S:6 = 12.3 ngJml,
respectively. These cotinine levels are based on blood'
samples drawn in the morning before that day's exposure to
ETS. Given the 20-h~ half-life of cotinine in the blood, the
steady state cotinine levels at the end of the daily exposure
period would be approximately <1, 12 and 31.2 nglml,,
respecuvel,v; for the control and low and high~ ETS groups.
There was a linear relation betweendog cotinine levels in
plasma and log average respirable suspended particulate
concentrations measured by Piezobalance (r = 0!84, p <
0.001) (Fig. 4).
Morpbologic studies. Figure 5 shows the percentage of'
total aortic and pulmonary artery surface area covered by
Figure 5. Percent of aortic an& pulmonary artery, surface areas
covered' by atherosclerotic lesions for each group, There is a
significant (p < 0.001) dose-response relation for both vessels. Error
bars are SESt. Abbreviations as in Figure 4.
Conua
Ers-t
ETSH
Aorta
iu4naosry Art.ry
ZHU ET AL. 229
PASSIVE SMOKING INCREASES ATHEROSCLEROSIS
lipid lesions in the three expenmental groups. There was a
significann (p < 0.001) dose-response relation for, the extent
of lipidilesions for both the aorta and the pulmonary artery as
a functioniof'respirable suspended particulate concentration
measured by Piezobalance. Although the intercepts of the
dose-response relations for the two arteries are significantly
different (31.3 - 2.7% for the aorta vs. 23.0 - 2.6% for the
pulmonary artery, p < 0.05), the slopes are not (1.62 =
0.41%/t`ng%mt' vs. 1.69' - 0.39%imgim', p > 0.5). These
results indicate that, although the baseline levels of lipid
deposits in these two~ artenes are different, the effects of
exposure to ETS on~the two anenes are similar in terms of
increased lipid deposits. There were also positive correla-
tions (r = 0.5; p< 0.001) between the percent of lipid lesions
in both arteries and the average CO level5. As with the
relation between lesions and particulate concentration.
the aorta initiallN ha& more lipid deposits than did the
pulmonary artery, but both vessels showed similar increases.
(-0.5%/ppm) in lipid deposits with ETS exposure as,CO was
increased. Because particulate and CO levels are highly
correlated, we cannot say whether either or both (or other)
elements of the ETS are responsible for, the dose-dependent
increase in lipid deposits we observed. We can conclude
unequivocally that there were significant (p < 0.0010idose-
dependent increases in lipid~ deposits on both vessels with
increasing ETS exposure.
Platelet fnnction. Data on bleeding time. platelet aggre-
gate ratio and platelet count are shown in Table 3. Bleeding
times at week 12 in the low an& high ETS groups were
significantly shorter than those in.the control group (68 = 15..
68 = 1,8 vs., 86 = 17 s. respectively, p < 0.001). This result
demonstrates that there were large (20%) changes in bleed-
ing time at low levels of exposure to ETS and that further
increases in~ezposure did not produce anadditional effect,.
The platelet aggregate ratio at week 12 in the high ETS group
may have been lower than the control level (79.4- 10.7 vs.
88.0 :t 12.2%, p = 0:07 by paired r test), reflecting an
increase in platelet aggregates in the high ETS group: The
platelet counts were modestly decreased to a similar extent
in all three groups (Table 3). The changes in platelet count
before and afterexposure were -36 = 97, -84 = 131 and
-94 = 95 (p = 0:151 by ANOVA), respectively. These data
show effects on platelet function at low levels of ETS that do
not increase with further increases im dose. This result
suggests that platelets are sensitive to~ low, levels of ETS.
after which the effect is saturated'.
Discussion
Active smoking has consistently been, identified as a
major risk factor for ischemic heart disease. Exposure to
environmental tobacco smoke (ETS), as passive smoking,
has now been linked to heart disease in nonsmokers (4.6.17-
19). Epid'emiologic studies conducted in a variety of loca-
tions reflect about a 30~7o increase in risk of death from
ischemic hean disease or myocardial infarction among non-
®

230 ZHl; : ET AL.
, PASSIVE SMOKING INCREASES ATHEROSCLEROSIS
_Table 3. Effects of Environrnental Tobacco Smoke on Platelet Function in Cholesterol.Fed' Rabbits
JACC Vol. 21.,No, I
January,1993125-32
Blteding Time (s) Platelet Aggregauond%) Platelet Caunt (1U'1.
Group Before After Before After Before After
Control In,= 32) 78 t 23 86 _. 17 84.1 _ 14.6 80:9 - t3.7 295 - 89 2.56 : 89
Low ETS In = 16)~ 73 t 26 68 t IS 83.9 _ 11.8 8Z6 _ 14.3 352 = 130 268 _ 95.
High ETS in = 161 77 , 2 19 68 = 18 ' 87.9 t 12.3 79.4 : 10.7' 372 = 140 293 _ 76
p < 0:01 compared with values in the controfgroupl ip = 0:07~ compared with values in the high ETS
group before exposure. Values are expressed as mean
value _ SD. Abbreviations as in Table 2.
smokers living with smokers (4-6,18). The larger studies
also demonstrate a significant dose-response effect, with
greater exposure to ETS associated with a greater risk of
death from heart disease.
Our present study shows that passive smoking signifi-
cantly increases aortic andipulmonary artery atherosclerosis
in cholesterol-fed rabbits in a dose-dependent manner. There
was a strong positive correlation between the percent of
atherosclerotic lesions and the average CO or particulate
concentrationswith the lipid deposits in arteries in~the high
dose group nearly doubling in just 10 weeks. These results
are consistent with epidemioiogic studies demonstrating that
ETS increases the risk of death from heart disease.
Passive smoking and atherosclerosis. Smoking has long
been recognized as one of the major risk factors for adult
~ coronary heart disease, peripheral arterial disease, abdomi-
nal aortic aneurysm and stroke. Clinical investigations in&
cated that the proportion of intimal' surface involved with
atherosclerotic lesions in both the aorta an&the right coro-
nary artery was positively associated with serum very low
density lipoprotein and low density :ipoprotein cholesterol
and was negatively associatedvith serum HDL cholesterol.
The serum thiocyanate concentration, a marker for smoking,
was strongly associated with the prevalence of atheroscle-
rotic lesions, particularly in the abdominal aorta (20). Popu-
lation studies of passive smokers revealed that passive
smokers had significantly thicker carotid arterial walls than
those of persons who had never smoked passively or ac-
tively (8). Our results are consistent with what one would
expect from these clinical studies.
However, we observed much larger effects of ETS than
would be expected from a simple dose-based extrapolation
from high doses experienced by smokers to tbe lower doses
of smoke experienced! by nonsmokers. Our results suggestt
that nonsmokers may be more sensitive to the toxins in ETS
than smokers are, perhaps because smokers have somehow
adapted to the chronic poisoning associated with active
smoking. It is also probable that some of the biochemical
systems involved are very sensitive to ETS but saturate at
low doses.
Passive smoking and serum lipids. Epidemiologic studies
: have suggested that there is a dose-response relation be-
tween the number of cigarettes smokedlday and increasing
levels of plasma cholesterol'(2T). The HDL cholesterol level
was lower in childien exposed to ETS; the HDL2 subffraction
was reduced in boys, whereas the HDL3 subfraction was
reduced in girls. As a result, exposure of children to ETS
may increase the risk of premature coronary heart disease
(22). Nonsmoking adolescents with two smoking parents had'
significantly higher plasma cotinine concentrations after an
adjustment for other factors than di& ad'olescents whose
parents did not smoke. A plasma cotinine concentration
>2.5 Fcglml was associated with an 8.9°lo greater ratio of total
cholesterol to HDL cholesterol an& a 6.8% lower HDL
cholesterol level (23). Similar results have been reported for
nonsmoking adults exposed to ETS in the workplace (9).
These results suggest that passive smoking, like active
smoking, leads to alter*ations in lipid profiles predictive of an
increased risk of atherosclerosis.
The present study, however, showed no significant dif-
ferences in total serum cholesterol, triglycerides, HDL-
cholesterol, cholesterol-weeks, change in cholesterol,
change in triglycerides or change in HDL cholesterol be-
tween, the control group and the two passive smoking
groups.
To test whether the changes in~ lipid lesions associated
with~ ETS exposure could: be a result of differences in
cholesterol levels, we performed a multiple regression anal-
ysis withe the percent aorta and pulmonary anery with lipid
deposits 4 the dependent variables and cholesterol, triglyc-
erides and HDL cholesterol7evels at 2 and 12 weeks (that is,
before and after ETS exposure control) and ETS concentra-
tion as the independent variables. In both cases ETS expo-
sure was still significaa(p < 0:001) and positively associated
with ETS dose after accounting for differences in serum
cholesterol. Therefore, the increase in atherosclerotic le-
sions in the cholesterol-fed rabbits exposed w ETS wass
independent of changes in serum lipids in the present study.
Passive smoking and platelet fnnction. In addition to their
role in acute thrombus formation, platelets have also been~
implicated in the development of atherosclerosis. Davis et
al. ('17) reported'that mean values of the platelet aggregate
ratio before and after passive smoking were 0.87 and 0:78,
respectively (p = 0.002): These valUes are similar to those
we observed in the high ETS group (Table 3). They found
that passive smoking increased platelet aggregation with a
magnitude similar to that observed in active smoking. The
effects of cigarette smoking on the levels of piatelet-
activating factor (PAF), one of the most potent proinflaal-
matory agents, or PAF-Gke lipids were studied (24,25). The
.-N
~..~~

JACC Vol. '-1. No li
January 1993.:25-3:
results showed that, the values of PAF-like lipidsin both
LDL and HDL in smokers increased sigrtificantly after
smoking, and that the activiny of plasma enzyme, PAF
acetylhydrolase. was inhibited by cigarette smoke extract in
a dose-dependent manner. The charge alteration, reactions
and'PAF-acetylhydrolase inhibition appear to be localized at
differenb sites on the lipoprotein molecule. Thus, the ob-
served inhibition may account for the increase in plasma
PAF concentration that is known to occur in smokers.
Inithe present study, bleeding times at week 12 in the two
ETS groups, were significantly, shorter than in the control
group (p < 0,001), and'platelet aggregate ratio at week 12 in
the high ETS group was borderline lower than the control
level (p = 0.07): suggesting increased platelet aggregate
formation. These results suggest that the effects of passive
smoking may be mediated. at least in part, by altered platelet
function.
Passive smoking and arterial endothelium: People ex-
posed to ETS had a significantly thicker carotid artery wall
than that of nonexposed persons who had never smoked,
with the increase in wall thickness increasing with greater
ETS exposure (8). Such epidemiologic studies are comple-
mented by a variety of physiologic and biochemical data
showing that ETS damages arterial endothelium. Davis et al.
(17) reported that mean values of anuclear end'othelial cell
carcasses in venous blood'before andafter passive smokingg
were 2.8 and 3.7 (p = 0.002). The appearance of these cell
carcasses indicates damage to the endothelium, which is the
initiating step in the atherosclerotic process. Bondjers et al.
(26) hypothesized that the effect~ of smoking might be medi-
ated by increased catechol'amine levels. The endotieliall
injury induced by smoking could be inhibited by metoprolol,,
supporting this hypothesis.
Other possible mechanisms of atherogenesis induced by
F.TS. Clinical studies (27-29) in smokers with~ coronary
aftery disease show that smoking increases myocardial
oxygen demands and' such~ indicators as the rate-pressure
product)- Also, smoking-induced': coronary vasoconstriction,
which is due to an alpha-adrenergically mediated increase in
coronary artery tone, is prevented by calcium antagonist
drugs and nitroglycerin. Thus, smoking can adversely affect
the balance between myocardial oxygen supply and demand.
Several animal studies (5) have also shown that injections
of polycyclic aromatic hydrocarbons, in particular 7,12-
dimethylbenz(a,h) anthracene and benzo(a)pyrene, signifi-
cantly increase aortic plaque and accelerate the develbpmentt
of atherosclerosis. These studies provide evidence thatt
known carcinogenic chemicals can be athcrogenic as wel1L In
animal'4;xpPtiments, ETS also depresses cellular respiration
at the level of mitochondria (30). The effects of ETS on
c:urliov.tscular function, platelet function, neutrophili func-
tii;n and plaque formation are the probable mechanisms
le-t;r., ~,) he;ttt disease (4,5).
Dose and duration. In the present study, the average
concentrations of'air nicotine. CO and particles d'uring 7 h eF
exposure in the high ETS group were 30-fold, 3-fold and
zHU ET AL. '_3l'
PASSIVE SMOKING INCREASES ATHEROSCLEROSIS
10-fold higher than in the low ETS group (1.040 vs. 30 µg!m3.
60 vs. 19 ppm. 13.8 vs. 1.2 mg/rrt3, respectively) Human
exposure studies (5,11,13) showed thannicotine and respira-
ble suspended particulate levels in restaurants ranged1from I
to 25 Fcgim3 and 55 to 600 µgim3', respectively; respirable
suspended particulate levels were 589 to 11,140 µg(m3 in bars
an& bingo halls ('3), The U.S. National Ambient Air Quality.
Standard for respirable particles is 50 µg.<m'' (annual aver-
age). The nicotine levels in smoking sections on airplaneswere found to be 50 to 100 µg/m3. Air
nicotine. CO and
respirable suspended particulate levels in some public
smoking rooms were foun& to range from 50'to 500 µg%m3,
5 to 50 ppm and 0.50-1.95 mg/m3; respectively. Thus, the
levels we observedin the high ETS group are a factor of 2 to
10 higher than those observed in routine human environ-
ments and the levels in the low ETS group are similar to
those of heavily smoking-polluted, but realistic human
environments.
The studies (31) reviewed show that cotinine measure-
ments are sensitive to the current exposure of nonsmokers
to other people's tobacco smoke withia half-life of ='_0 h in
the blood. Plasma cotinine levels after 2 hi of exposure to
ETS in a heavily polluted public house were 7.33 ng.1m1. The
cotinine levels in plasma we observed in the low ETS group
were comparable to those of a heavily polluted room.
whereas those in the high ETS gnoupiwere two- to fourfold'
higher.
Despite exposure to higher than routine human exposure
levels, every rabbit in the two ETS groups tolerated the
exposure well during the I0week exposure penod. There
were no differences in food consumption or weighn gain
among the different' experimental groups. The differences
between these experimental exposure levels and' actual
humane exposure levelk were small compared with those of
other.studies of environmental toxins, where extrapolations
>5 to 6 orders of magnitude are common. Indeed. our low
ETS group represented realisvic exposure for people who
work imsmoking environments, such as bartenders or wait-
ers working in the smoking section of a restaurant.
Conclusioas. These data indicate that the exposure of
lipid-fed'rabbits to passive smoke adversely affects platelet
function and significantly increases atherosclerotic lesions in
the aorta and pulmonary artery. This increase imatheroscle-
rosis is independent of changes in serum lipids and has a
dose-response relation. These results are consistent with
epidemiolbgic studies demonstrating that ETS increases the
risk of death 1rom heart disease.
Gratefuiappreciauon is given to James Repacc of the Envtroruacntal Protce-
tion Agency, Waslungton: DC. wayne Ott of EPA and Sianford Ltuvcrsny..
tkpanment of Sutistics- Stanford, California and~ t.ee t.angan of, 1.aapn
Producu. Inc. for, theu many thoughtful suggestions. We acknowledge John
Hudson of the Electronic FacilitiesCardiovasculir Research Institute. l,'ru-
versity of California; San Francisco. San Francisco, California for techuucal
usistance. and Paul E. Sumner. San Franmsco for mva)uablc asslsunce In,
the platekt aggregation studies. We alsoahanY S. Kathanne Hammond of the
~

t
4
232 ZHU ET AL.
PASSIVE SMOKSNG INCRFASES ATHFROSCLEROS1S
University of Massachusetts, Medical School; Worcester. Massachusetts for
help in analying tbe au nicotine levels.
References.
1., US Public Health Service. The health consequences of involUn-
tary smoking: a report of~tlie Surgeon General. DHS1CDCl87-839'8, 1986.,
2. National'Research Council. Environmental Tobacco Smoke: Measuring
Exposure and Assessing Health Effects. Washington DC: National Aead:
emy Press. 1986,
3, Repace JL. lndoor, concentrauons of environmental tobacco smoke: held
survey. In: O'Neill 1K. Btunnemann KD: Dodet B. Hoffmann D, eds.
Environmental Carcinogens. Methods of Analysis and Exposure Mea-
suremenr, (Vol 9, Passive Smoking): Lyon: IARC Scientific Publications.
1987:141+59.
4. Taylor, AE. Johnson DC, Kizemi H. Environmental tobacco smoke and
cardiovascular disease: a position paper from the Council on Canliopul-
monary and Critical Care. American Heatt Association. Circulation
1992;86il-4.
5. Glantz SA. Parmley WW. Passive smoking and heart,disease::epidemiol-
ogy, physiologyand biochemistry. Circulation 1991:83:1-12.
6. Steenland K. Passive smoking and the risk of heart disease. JAMA
1992 ~267:94-9 :
7. US Environmental Protection Agency. Respiratory health effects of
passive smoking: lung cancer and other disorders. EPAl60fY69N006B..
May 1992.
8. Howard' G, Szklo M. Evans G- Tell G. Eckfeldt I., Heiss G. Passive
smoking and carotid artery wall thickness: the ARIC study fabstrl:
Circulation 199^_;85:8fi2.
9~ White IR, Cnqui M, Kulik JA. Froeb HF. Sinshelmer PJ. Serum
lipoprotein in nonsmokers chronically exposed to tobacco smoke in the
workplace. 8th World Conferonce on Tobacco or Health, Buenos Aires
Argentina. March 30-April 3, 1992 (abstr):
10. Fisher ER, Wholey M.,Shoemaker R. Cigarette smoking and'cholesterol
atherosclerosis of rabbits. Arch Padtol 1974:98:418-21.
11. Repace J, Lowrey AH. Indoor air pollution, tobacco smoke, and public
health. Science 198+)'~208:464-72.
12. Ingebrethsen BJ, Heavner DL. Angel AL. Conner JM, Steiehen TI.
Green CR. A comparative study of environmental tobacco smoke partic-
ulate mass measurements in an environmenul chamber. J Air Pollut
ControllA'ssoc 1988:38:413-7.
13. Hammond SK. Leaderer BP. A diffusion monitor to measurrexposure to
passive smoking. Environ Sci Technol 198721 494-7:
14. Jacob P, Wilson M, Benowitz NL. Improved gas chromatographic
method1or the determination of nicotine and cotiaiae in biologrc fluids.
J!Chromatog 1981tZ'r2:61-70.
15. Jacob P, Yu L, Wilson M, Benowitz NL. Selected ion anottitoring method
for detertninanon of nicotine, coeinine, and deutetium-labelled analogs:
JACC Vol. 21L No. I
Januarp 1993:)..25-32
absence of an isotope effect in the ciearrnce of (5)-nieotiise-3',3'd= in
humans. Biol Mass Spectrom 19912-0:247-52.
16. Wu KK. Hoak JC. A new metDod for the quanutauve detection of plhtelet
aggrngates in pauents with anenal insuffteiency. Lancet 1974:1i1:924-6:
17: Davis 1. Shelton L. Watanabe I, Arnold 1. Passive smoking affects
endothellum and platelet. Arch lntern Med'1989:149:386-9,
18 . Wells A. An estiaute of adult mortality in the United States from passive
smoking. Environ lat 19g8a4:249-65.
19. Kristensen T. Cardiovascular diseases and the work eovironmene:, a
critical review of the epidertuologic literaturo on chemical factors. Scand
J Work Environ Health 1989:15:245-64.
20. PDA.Y Research Group. Relationship of uherosclerosis in young men to
serum bpoprotein cholesterol concentrations and smoking. JAMA 1990;,
264:3018-24.
21. Muscat JE, Harris RE, Haley NY. Wynd'er EL. Cigarette smoking and'
plasnu cholesterol. Am Heart 1 1991':121:141-7.
22. Moskowitz WB, MosteUer M, Schieken RM, et al.. Lipoprotein and
oxygen transport altenuons in passive smoking preadolescent childreo:
the MCV'twin study. Circulation 1990:81:586-92.
23. Feldman 3, Shenker 1R. Etzel RA. et al. Passive smoking ahers lipid
profiles in adoleseents. Pedtatncs 1991:88:259-64.
24, Ihuizumi T, Sa[oh K. Yoshida H, Kawamura Y. Hiramoto M. Takamatsu
5, Effect of cigarette smoking on the levels of platelet-acuvaung factor.
like Gptd(s)' in plasma hpoproteins:. Atherosclerosis 1991:87;47-55:.
?S. Miyaura S! Eguchi H. Johnston JM. Effect of cigarette smokrextt9ct,on
the metabolism of the proi.ttAammatory autatoid, platelet-activatutg fac-
tort Cirr Res 1992;70;341-7.
26: Bondjera G, , Haasson G, Olsson G, Pettersson K. Smoking, cita
cholamme and their effects on endotlielial cell integrity. lh:,Diana JN. ed.
Tobacco Smoking and Atherosclerosis: Pathogrnesis and Cellular Mecb-
anisms. New York: London: Plcaum Press. 1990:51-6:
27. Nicod P. RetinR, Winniford MD, CampbelliWB, Firth BG.,Hillis LD;.
Acute systemic and coronary hetnodynantic and serologic responses to
cigarette smoking in long-term smokers with atherosclerotic coronary
artery disease. J Am Coll Cardiol'1 1984;4:964-71.
28. Winnifor,i MD, Wheelan KR, Kremers MS. et, al. Smoking-induced
coronary vasoconstnction in patients with atherosclerotic coronary, artery
disease: evidence for adtenergically mediated alterations in coronary,
artery tone. Cirtulation 1986;7i:662-7:
29:, Winruford MD. Jansen DE. Reynolds GA. Apprill P, Black WH, Hillls
LD:,Cigarette smoking-induced'eoronary vasoconstrieuon in atherosck-
rouc coronary artery disease and prevention by calcium antagonists and
nitrog.fycersn. Am I Cardiol 198759:203-7.
30. Gvozdjakova A, Bada VSany L, et al. Smoke cardiomyopathy: distur-
bance of oxidative process in myocardial mitochondtia. Cardiovasc Res
1984;18:229-32.
31. Jarvis MJ.,App6ution of biocbemical intake markers to passive smoking
measuremeot and risk estitnation: Mutat Res 1989'-l2.1:101-10.
